The American Journal of Managed Care8h
Amyloid-Targeting Therapies in Alzheimer Disease: Mechanisms of Action, Efficacy, and Safety Considerations
Panelists discuss how amyloid-targeting therapies for Alzheimer disease represent a breakthrough drug class that works by ...
The American Journal of Managed Care8h
Real-World Implications of Changes in CDR-SB Score in Patients Receiving Amyloid-Targeting Therapy
Panelists discuss how clinicians should interpret Clinical Dementia Rating-Sum of Boxes (CDR-SB) score changes by correlating ...
Health on MSN14h
Hypopigmentation: Types, Causes, Diagnosis, Treatment
Hypopigmentation is a chronic condition in which areas of the skin are lighter in color than normal. Causes may include ...
EMBO Press7h
CD47-amyloid-β-CD74 signaling triggers adaptive immunosuppression in sepsis
CD47-amyloid-β-CD74 signaling is a key driver of adaptive immunosuppression in sepsis, suppressing B cells and impairing ...
PipelineReview.com12h
Meitheal Pharmaceuticals Announces Approval and Launch of Liraglutide Injection in the United States
CHICAGO, IL, USA I April 03, 2025 I Meitheal Pharmaceuticals, Inc. (“Meitheal”), a fully integrated biopharmaceutical company based in Chicago focused on the ...
Harvard Medical School19h
Changing for the Better
From personal goals to professional aspirations to system-level reform, the ability to change often remains maddeningly out of reach — even with all the desire and motivation in the world. Two Harvard ...